Omnidermal

Curated by Signal

Developer of an AI enabled wound monitoring device

Overview

Omnidermal (spin-off of the Turin Polytechnic) is developing AI-enabled devices for skin and wound care. The Woundviewer is used for monitoring, diagnosing and documenting wounds by the doctors. It enables doctors to view and manage the patient list, details and medical records for monitoring the treatment. It also can be used to diagnose the progression of the wound over time in real-time and provides ulcer parameters by analyzing the images.

Key facts

Founded: 2017
Headquarters: Parma, Italy
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

GymIA
AI-powered app offering virtual fitness and nutrition programs
Health TechnologyIvrea, Italy
Brainbow
AI-powered neurological condition assessment tool for healthcare professionals
Health TechnologySasso, Italy
Unique Care
Provider of a SaaS-based healthcare emergency helpline management software for healthcare organizations
Health TechnologyTurin, Italy

About Omnidermal

What does Omnidermal do?

Omnidermal (spin-off of the Turin Polytechnic) is developing AI-enabled devices for skin and wound care.

Where is Omnidermal headquartered?

Omnidermal is headquartered in Parma, Italy.

When was Omnidermal founded?

Omnidermal was founded in 2017.

Which sector is Omnidermal in?

Omnidermal operates in Health Technology.

Who are Omnidermal's competitors?

Companies similar to Omnidermal include GymIA, Brainbow, and Unique Care.